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Abstract:
We investigated auras in patients with drug-resistant temporal lobe epilepsy (TLE) and mesial
temporal sclerosis (MTS). We also investigated the clinical differences between patients with
MTS and abdominal auras and those with MTS and non-mesial temporal auras. All patients with
drug-resistant TLE and unilateral MTS who underwent epilepsy surgery at Jefferson
Comprehensive Epilepsy Center from 1986 through 2014 were evaluated. Patients with good
postoperative seizure outcome were investigated. One hundred forty-nine patients (71 males and
78 females) were studied. Thirty-one patients (20.8%) reported no auras, while 29 patients
(19.5%) reported abdominal aura, and 30 patients (20.1%) reported non-mesial temporal auras;
16 patients (10.7%) had sensory auras, 11 patients (7.4%) had auditory auras, and five patients
(3.4%) reported visual auras. A history of preoperative tonic-clonic seizures was strongly
associated with non-mesial temporal auras (odds ratio 3.8; 95% CI: 1.15-12.98; p = 0.02). About
one-fifth of patients who had MTS in their MRI and responded well to surgery reported auras
that are historically associated with non-mesial temporal structures. However, the presence of
presumed non-mesial temporal auras in a patient with MTS may herald a more widespread
epileptogenic zone.

Key words: Aura; Surgery; Temporal lobe epilepsy.
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Introduction
Aura is a subjective ictal event that may precede a seizure and constitute a cardinal
feature of focal epilepsies including temporal lobe epilepsy (TLE) [1]. Mesial temporal sclerosis
(MTS) is the most common pathological abnormality associated with TLE [2, 3]. No clinical
information or diagnostic method directly and definitively assesses the location and extent of the
epileptogenic zone in focal epilepsies. However, concordance of multiple types of clinical data
helps form a hypothesis regarding the localization of the epileptogenic zone. As the initial ictal
symptoms, auras can provide important localizing and lateralizing information useful in
determining the location of the epileptogenic zone [4]. Historically, some types of auras have
been associated with TLE (e.g., abdominal auras, affective auras, and mnemonic auras), while
some others (e.g., sensory auras) have been associated with non-temporal epilepsies [4]. In
previous studies, abdominal auras have often been associated with mesial temporal lobe epilepsy
[5-7]; however, other types of auras may also occur in these patients [5].
In this study, we investigated the types of auras in patients with drug-resistant TLE and
unilateral MTS, who responded well to surgery. Rational for excluding the patients who failed to
respond to surgery was to have a very uniform group of patients who preoperatively had MRIMTS and postoperatively responded well to the designed therapy with respect to seizure
outcome. Response to appropriate treatment (i.e., standard anterior temporal lobectomy) was an
indirect evidence for accuracy of the clinical diagnosis and also decreases the possibility of other
variants of TLE such as temporal plus epilepsies [8], at least to some extent. We also
investigated the potential clinical differences between patients with MTS and abdominal auras
and those with MTS and non-mesial temporal auras (i.e., sensory, auditory or visual auras); to
our knowledge, this comparison has never been done before. Such information may lead to a
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better understanding of the clinical manifestations of MTS. This may ultimately lead to a better
understanding of the pathophysiology of MTS-TLE; for example, by providing the background
for future network studies (e.g., fMRI studies).

Methods
In this retrospective study, all patients with a clinical diagnosis of drug-resistant TLE and
unilateral MTS who underwent successful temporal lobectomy for epilepsy at Jefferson
Comprehensive Epilepsy Center were recruited. Patients were prospectively registered in a
database from 1986 through 2014. The diagnosis of MTS-TLE was based on clinical grounds
(history and semiology), electroencephalographic (EEG) findings, and imaging [magnetic
resonance imaging (MRI)]. There was no age limit to enter the study. For all patients, a
comprehensive presurgical evaluation including a 1.5 Tesla brain MRI (epilepsy protocol) was
performed. Magnetic resonance imaging studies were analyzed by neurologists and
neuroradiologists with expertise in epilepsy. We classified patients as having MTS if they had
clear signs of mesial temporal atrophy and/or sclerosis in their MRI. Patients with normal MRI
and those with bilateral MTS or dual pathology and also, patients with concomitant psychogenic
nonepileptic seizures were excluded from this study. Pathology specimens were reviewed by
pathologists, but most results were not sufficient to provide a precise pathological classification.
All patients had a standard anterior temporal lobectomy. The patients were followed for
up to five years after surgery (in many patients the data was missing beyond five years of followup). Seizure outcome was monitored periodically by office visits (by the treating physician),
telephone contacts, and letters (by the nurse practitioners). Patients with postoperative seizure
freedom for at least one year before their last visit were studied. Aura was not considered as a
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relapse; only postoperative tonic-clonic seizures and complex partial seizures were considered as
relapse.
Age, gender, age at seizure onset (i.e., the first afebrile seizure), seizure type(s), MRI
findings, date of surgery, date of the first relapse (if any) and date of the last contact with all
patients were registered routinely. Source of information about auras was the history obtained by
the board certified neurologists (epileptologists). Six groups of patients were identified,
according to their preoperative auras. The first group included patients with abdominal aura
(abdominal discomfort including nausea, emptiness, tightness, butterflies, malaise, pain, or
hunger; sensation may rise to chest or throat); the second group of patients reported affective
auras (i.e., fear, anxiety, depression, joy, or anger); the third group reported mnemonic auras
[i.e., feelings of familiarity (déjà-vu) or unfamiliarity (jamais-vu)]; the fourth group had nonmesial temporal auras (i.e., sensory, auditory and visual); the fifth group reported other types of
auras (e.g., dizziness, strange feelings, etc.); and finally, the last group did not report an aura
preceding their seizures.
Demographic variables and relevant clinical variables were summarized descriptively to
characterize the study population. Patients with non-mesial temporal auras (i.e., sensory, auditory
or visual auras) were compared with patients who had abdominal auras. Pearson Chi-Square, ttest, and Kolmogorov-Smirnov test were used for statistical analyses. P value less than 0.05 was
considered as significant. Variables that were significant or nearly so in univariate tests were
assessed in a logistic regression model. Odds ratio and 95% confidence interval (CI) were
calculated. This study was conducted with the approval by Thomas Jefferson University
Institutional Review Board.
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Results
During the study period, 794 patients had temporal lobe surgery for drug-resistant
temporal lobe epilepsy. Magnetic resonance imaging results were as follows: MTS in 306, dual
pathology in 19, other findings in 278, normal results in 168, and missing results in 23 patients.
Two-hundred and thirty-seven patients had complete data with regard to preoperative seizure
information (i.e., aura types). Of these, 149 patients (62.8%) reported no seizure for more than
one year before their last visit and were studied. We included 71 men and 78 women. Age at
epilepsy onset was 13.8 ± 11.5 years. Age at surgery was 36.5 ± 11.2 years. Thirty-one patients
(20.8%) reported no auras, while 29 patients (19.5%) reported abdominal aura, 10 (6.4%) had
affective aura, 7 (4.7%) reported mnemonic aura, 30 (20.1%) reported non-mesial temporal auras
and the remainder had other auras (e.g., indescribable feeling, dizziness, or headache). Among
patients with non-mesial temporal auras, 16 patients (10.7%) had sensory auras (eight patients as
a single aura and eight as a part of multiple auras), 11 patients (7.4%) had auditory auras (seven
patients as a single aura and four as a part of multiple auras), and five patients (3.4%) reported
visual auras (two patients as a single aura and three as a part of multiple auras). Two patients had
multiple non-mesial temporal auras (one had sensory and auditory and the other had visual and
auditory auras). Patients with non-mesial temporal auras (30 patients) were compared with
patients who had abdominal auras (29 patients) in Table 1. Negative history of childhood febrile
seizures and positive history of preoperative tonic-clonic seizures were associated with nonmesial temporal auras in univariate analyses. We then performed a logistic regression analysis,
assessing these two variables. A history of preoperative tonic-clonic seizures was strongly
associated with non-mesial temporal auras compared with patients with abdominal auras (odds
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ratio 3.8; 95% CI: 1.15-12.98; p = 0.02; 70.7% of the cases were correctly predicted by the
model). History of childhood febrile seizures (p = 0.08) was not a significant risk factor.

Discussion
As the first ictal symptoms, auras can provide important information useful in
determining the location of the epileptogenic zone in patients with focal epilepsy. Abdominal
auras include sensations of nausea, pain, or indescribable discomfort in the abdominal or
periumbilical area that can be static, rise to the chest and throat, or descend into the lower
abdominal region [4]. The seizure onset zone for abdominal auras may be the anterior insular
cortex, frontal operculum, or mesial temporal structures [4]. However, abdominal auras have
often been associated with mesial temporal lobe epilepsy [5-7]. In a previous study [7], presence
of abdominal aura was a good prognostic indicator for seizure free outcome after temporal
lobectomy in patients with MTS-TLE. On the other hand, it is not unusual to observe other types
of auras in patients with MTS-TLE. Similarly, it is not rare to observe abdominal auras in other
focal epilepsy syndromes [9]. In one previous study [5], abdominal auras were more frequent
with TLE (117 of 223 patients, 52%) than in extratemporal epilepsy (13 of 113 patients, 12%, p
< 0.0001) and more frequent in mesial TLE (70 of 110 patients, 64%) than in neocortical TLE
(16 of 41 patients, 39%, p = 0.007). In the current study, we observed that about one-fifth of the
patients who had MTS in their MRI and responded well to standard anterior temporal lobectomy
reported auras that are historically associated with non-mesial temporal structures (i.e., sensory,
auditory or visual auras); one-fifth had abdominal auras and another one-fifth had no auras
associated with their seizures. In a previous study [9], of 333 patients who had undergone
temporal lobectomy for drug- resistant TLE, 26 (7.8%) patients had somatosensory auras. These
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authors observed that [10], compared to their non-somatosensory auras counterparts, patients
with somatosensory auras had the same clinical and imaging characteristics, but had a higher rate
of breakthrough seizures, although most (54%) were still able to achieve Engel class of I
outcome after surgery [10]. In another study of 400 MTS-TLE patients [11], 12% of the patients
reported somatosensory auras; 10% had visual and 7% reported auditory auras. This study also
found that patients with different auras could have good surgery outcome [11]. These findings
are similar to ours and indicate that in a patient with drug-resistant seizures and mesial temporal
epilepsy, observation of a presumed non-mesial temporal aura should not deter from surgery as a
potential curative option. However, absence of abdominal auras may herald a lower chance of
seizure free outcome postoperatively in patients with MTS-TLE, as we observed in a previous
study [7]. This information should be discussed with the patients in a preoperative counselling
session.
Patients with MTS and non-mesial temporal auras (i.e., sensory, auditory or visual auras)
had few, but significant clinical differences compared with those with abdominal auras; a history
of preoperative tonic-clonic seizures was strongly associated with non-mesial temporal auras.
Presence of the presumed non-mesial temporal auras in a patient with MRI-MTS may herald a
more widespread epileptogenic zone compared with that in patients who report abdominal auras.
Alternatively, this may suggest a different epileptic network and spread pattern compared with
the network responsible for seizures in patients with abdominal aura. Our previous observation
that patients with drug-resistant MTS-TLE, who reported abdominal auras preceding their
seizures, fared better postoperatively with regard to seizure control compared to those with other
types of auras [7] support the hypothesis that a more restricted epileptogenic zone is responsible
for seizure generation in patients with abdominal auras. In addition, evidence obtained with
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fMRI suggests more widespread derangements in brain function and connectivity in TLE
patients with tonic-clonic seizures (compared with those without this seizure type) [12], and we
observed that a history of preoperative tonic-clonic seizures was strongly associated with nonmesial temporal auras. However, the hypothesis of various epileptic networks in patients with
different types of auras, despite a similar core of pathology (i.e., mesial temporal sclerosis),
could not be excluded. Future functional and structural connectivity studies and also precise
network analyses may answer to these questions.

Study limitations
This was a retrospective study and patient data came from a single institution. Also,
because this was a clinic-based series of the patients with drug-resistant MTS-TLE, they may not
represent the full spectrum of MTS-TLEs. Finally, pathology specimens were reviewed by
pathologists, but most results were not sufficient to provide a precise pathological classification
according to the international recommendation for a comprehensive neuropathologic workup of
epilepsy surgery brain tissue [13].
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Table 1. Patients with mesial temporal sclerosis and non-mesial temporal auras compared with
patients who had abdominal auras.
Patients with non-mesial

Patients with

p

temporal auras (30

abdominal auras (29

value

patients)

patients)

14 : 16

17 : 12

0.4

Age at epilepsy onset

13.2 ± 9.9 years

13.1 ± 11.7 years

0.7

Duration of disease

20.2 ± 13 years

22.2 ± 10.3 years

0.2

Childhood febrile seizure

8 out of 28* (28.6%)

16 out of 29 (55.2%)

0.04

Preoperative tonic-clonic

18 out of 29* (62.1%)

11 (37.9%)

0.06

Family history of epilepsy

6 out of 29* (20.7%)

12 out of 29 (41.4%)

0.1

MRI laterality of the lesion

14: 16

16: 13

0.6

0

0

--

3

0

0.08

Variables

Gender (Male: Female)

seizures

(Right : Left)
Posterior temporal or
occipital interictal
epileptiform discharges
Intracranial EEG
monitoring
*Some data were missing.
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